Cytek® Biosciences, Inc. ('Cytek Biosciences” or 'Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the third quarter ended September 30, 2025.
The study showcases an innovative and effective approach for large-scale genomic research of individual cells and viral ...
Surmodics (Nasdaq:SRDX) announced results from a sex-specific analysis of real-world patients in a study of its Pounce ...
This technology has vast potential to help patients but remains underutilized and underappreciated. The tools are there. What’s lacking are harmonized controls, regulatory guidelines and database ...
According to Nova One Advisor, the global exosome research market size is calculated at USD 225.72 million in 2025 and is ...
Vent Electric announced the release of the nVent SCHROFF Liquid Flow Through Module, used in rugged environments ...
For years, doctors have relied on familiar vital signs—heart rate, blood pressure, temperature and oxygen levels—to monitor someone's health. But researchers at the University of Missouri believe one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback